NEW YORK--(BUSINESS WIRE)--Aug 28, 2018--Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences.

Rouven Bergmann, chief financial officer, will present at the Citi 2018 Global Technology Conference on Wednesday, Sept. 5, 2018, in New York at 12:45 p.m. ET. Dr. Bergmann will also present at the Deutsche Bank Technology Conference on Wednesday, Sept. 12, 2018, in Las Vegas at 9:40 a.m. PT (12:40 p.m. ET).

A live audio webcast and replay of each presentation will be available at http://investor.mdsol.com.

About Medidata

Medidata is leading the digital transformation of life sciences, with the world's most used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by the #1 ranked industry experts, the Intelligent Platform for Life Sciences helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata serves more than 1,000 customers and partners worldwide and empowers more than 100,000 certified users every day to create hope for millions of patients. Discover the future of life sciences: www.mdsol.com

View source version on businesswire.com:https://www.businesswire.com/news/home/20180828005193/en/

CONTACT: Medidata Solutions:

Investors:

Betsy Frank,917-522-4620

bfrank@mdsol.com

or

Media:

Erik Snider, 646-362-2997

esnider@mdsol.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT INTERNET SOFTWARE OTHER TECHNOLOGY HEALTH RESEARCH SCIENCE GENERAL HEALTH

SOURCE: Medidata

Copyright Business Wire 2018.

PUB: 08/28/2018 08:30 AM/DISC: 08/28/2018 08:30 AM

http://www.businesswire.com/news/home/20180828005193/en